Kara W Chew

Title(s)Associate Professor-in-residence, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial. J Infect Dis. 2024 Nov 15; 230(5):1177-1186. Chew KW, Taiwo BO, Moser C, Daar ES, Wohl DA, Ritz J, Javan AC, Li JZ, Fischer W, Greninger AL, Bausch C, Luke T, Call R, Neytman G, Giganti MJ, Fletcher CV, Hughes MD, Eron JJ, Currier JS, Smith DM, ACTIV-2/A5401 Study Team . PMID: 39028902; PMCID: PMC11566225.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    2. Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial. Clin Infect Dis. 2024 Nov 11. Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, Ansari W, Harrington MA, Simón-Campos A, Chew KW, Pypstra R, Rusnak JM. PMID: 39523543.
      View in: PubMed   Mentions:    Fields:    
    3. 2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis. Clin Infect Dis. 2024 Oct 29. Bhimraj A, Falck-Ytter Y, Kim AY, Li JZ, Baden LR, Johnson S, Shafer RW, Shoham S, Tebas P, Bedimo R, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Martin GS, MacBrayne C, Nadig N, Nakamura MM, Shumaker AH, Tien P, Loveless J, Morgan RL, Gandhi RT. PMID: 39471458.
      View in: PubMed   Mentions:    Fields:    
    4. Prepandemic Metabolic Correlates of Coronavirus Disease 2019 (COVID-19) Severity and Long COVID Incidence in People Living With HIV. J Infect Dis. 2024 Oct 16; 230(4):912-918. Agrawal P, Giron LB, Singh S, Haw NJ, Goldman AR, Elkaeid M, Macatangay B, Palella FJ, Alcaide ML, Moran CA, Kassaye SG, Erdmann N, Chew KW, Floris-Moore M, Chandran A, Augenbraun MH, Sharma A, Palmer C, Landay AL, Peluso MJ, Keshavarzian A, Brown TT, Tien PC, Abdel-Mohsen M. PMID: 39011957.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19. Clin Infect Dis. 2024 Oct 15; 79(4):920-927. Jilg N, Giganti MJ, Chew KW, Shaw-Saliba K, Ritz J, Moser C, Evering TH, Daar ES, Eron JJ, Currier JS, Hughes MD, Lane HC, Dewar R, Smith DM, Li JZ. PMID: 39018444; PMCID: PMC11478775.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Viral and symptom rebound following anti-SARS-CoV-2 monoclonal antibody therapy in a randomized placebo-controlled trial. J Infect Dis. 2024 Oct 14. Chew KW, McGinley B, Moser C, Li JZ, Evering TH, Ritz J, Javan AC, Margolis D, Wohl DA, Hughes MD, Daar ES, Currier JS, Eron JJ, Smith DM, ACTIV-2/A5401 Study Team . PMID: 39400063.
      View in: PubMed   Mentions:    Fields:    
    7. National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned. Ann Intern Med. 2024 Oct 01. Gulick RM, Pau AK, Daar E, Evans L, Gandhi RT, Tebas P, Ridzon R, Masur H, Lane HC, NIH COVID-19 Treatment Guidelines Panel, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio P, Bhalla A, Burgess T, Campbell D, Cantrill S, Chew K, Chiotos K, Coopersmith C, Davey R, Dzierba A, Eisnor D, Eschenauer G, Francis J, Gallagher J, Glidden D, Goldenberg N, Grund B, Han A, Hardy E, Harrison C, Henderson L, Higgs E, Hinkson C, Hughes B, Johnson S, Keller M, Kim A, Knight R, Kuriakose S, Lennox J, Lerner A, Levy M, Li J, MacBrayne C, Martin G, Nadig N, Nason M, Patel P, Pavia A, Proschan M, Schulert G, Seam N, Sheikh V, Simpson S, Singh K, Swindells S, Tien P, Uyeki T, Waghmare A, Wolfe C, Yazdany J, Aberg J. PMID: 39348691.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Sexual behavior is linked to changes in gut microbiome and systemic inflammation that lead to HIV-1 infection in men who have sex with men. Commun Biol. 2024 Sep 14; 7(1):1145. Lin H, Chen Y, Abror-Lacks G, Price M, Morris A, Sun J, Palella F, Chew KW, Brown TT, Rinaldo CR, Peddada SD. PMID: 39277660; PMCID: PMC11401892.
      View in: PubMed   Mentions: Translation:HumansCells
    9. Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2. bioRxiv. 2024 Aug 19. Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A, Ritz J, Moser C, Eron JJ, Wohl DA, Currier JS, Daar ES, Greninger AL, Klekotka P, Grifoni A, Weiskopf D, Sette A, Peters B, Hughes MD, Chew KW, Smith DM, Crotty S, ACTIV-2/A5401 Study Team. PMID: 37961119; PMCID: PMC10634820.
      View in: PubMed   Mentions:
    10. Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2024 Aug 16; 230(2):394-402. Choudhary MC, Deo R, Evering TH, Chew KW, Giganti MJ, Moser C, Ritz J, Regan J, Flynn JP, Crain CR, Wohl DA, Currier JS, Eron JJ, Margolis D, Zhu Q, Zhon L, Ya L, Greninger AL, Hughes MD, Smith D, Daar ES, Li JZ. PMID: 38716969; PMCID: PMC11326811.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment. Pathog Immun. 2024; 9(2):58-78. Parikh UM, Heaps AL, Moisi D, Gordon KC, Mellors JW, Choudhary MC, Deo R, Moser C, Klekotka P, Landay AL, Currier JS, Eron JJ, Chew KW, Smith DM, Li JZ, Sieg SF, Team ACTIV-2/A5401 Study. PMID: 39165724; PMCID: PMC11335343.
      View in: PubMed   Mentions:
    12. SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback. J Infect Dis. 2024 Jul 22. Bloom N, Ramirez SI, Cohn H, Parikh UM, Heaps A, Sieg SF, Greninger A, Ritz J, Moser C, Eron JJ, Bajic G, Currier JS, Klekotka P, Wohl DA, Daar ES, Li J, Hughes MD, Chew KW, Smith DM, Crotty S, Coelho CH, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team . PMID: 39036987.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    13. Response to Drs de Grooth and Parienti. J Infect Dis. 2024 May 15; 229(5):1596. Giganti MJ, Chew KW, Eron JJ, Smith DM, Currier JS, Hughes MD. PMID: 38324658.
      View in: PubMed   Mentions:    Fields:    
    14. Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial. Pathog Immun. 2024; 9(1):138-155. Corado KC, Chew KW, Giganti MJ, Mu Y, Fletcher CV, Currier JS, Daar ES, Wohl DA, Li JZ, Moser CB, Ritz J, Javan AC, Neytman G, Caskey M, Hughes MD, Smith DM, Eron JJ, ACTIV-2/A5401 Study Team. PMID: 38746756; PMCID: PMC11093219.
      View in: PubMed   Mentions:
    15. Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. PLoS Pathog. 2024 Apr; 20(4):e1011680. Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS, ACTIV-2/A5401 Study Team. PMID: 38635853; PMCID: PMC11060554.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    16. Evaluation of GeneXpert and advanced biological laboratories UltraGene HCV diagnostic detection and performance against Roche real time PCR in Myanmar. J Clin Virol. 2024 04; 171:105653. Pisa P, Kinge CW, Chasela C, Mothibi E, Thaung YM, Thwin HT, Aung NM, Chew KW, Gandhi MM, Clint C, Minior T, Lwin AA, Freiman MJ, Kyi KP, Sein YY, Marange F, van der Horst C, Mohamed S, Barralon M, Sanne I. PMID: 38408420; PMCID: PMC11178258.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    17. The effect of sexual behavior on HIV-1 seroconversion is mediated by the gut microbiome and proinflammatory cytokines. Res Sq. 2024 Jan 24. Lin H, Chen Y, Abror G, Price M, Morris A, Sun J, Palella F, Chew KW, Brown TT, Rinaldo CR, Peddada SD. PMID: 38343862; PMCID: PMC10854284.
      View in: PubMed   Mentions:
    18. SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback. bioRxiv. 2023 Nov 22. Coelho CH, Bloom N, Ramirez SI, Parikh UM, Heaps A, Sieg SF, Greninger A, Ritz J, Moser C, Eron JJ, Currier JS, Klekotka P, Wohl DA, Daar ES, Li J, Hughes MD, Chew KW, Smith DM, Crotty S, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. PMID: 38045374; PMCID: PMC10690233.
      View in: PubMed   Mentions:
    19. COVID-19 Therapeutics for Nonhospitalized Patients-Updates and Future Directions. JAMA. 2023 Oct 24; 330(16):1519-1520. Chew KW, Malani PN, Gandhi RT. PMID: 37773595.
      View in: PubMed   Mentions: 2     Fields:    
    20. Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial. EClinicalMedicine. 2023 Nov; 65:102250. Jagannathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Main MJ, Monk PD, Javan AC, Li JZ, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W, ACTIV-2/A5401 Study Team. PMID: 37855026; PMCID: PMC10579289.
      View in: PubMed   Mentions: 3  
    21. One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial. Clin Infect Dis. 2023 10 05; 77(7):941-949. Jilg N, Chew KW, Giganti MJ, Daar ES, Wohl DA, Javan AC, Kantor A, Moser C, Coombs RW, Neytman G, Hoover K, Jana A, Hart PA, Greninger AL, Szurgot B, Eron JJ, Currier JS, Hughes MD, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37279602; PMCID: PMC10552586.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    22. Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation. AIDS. 2024 03 01; 38(3):317-327. Gandhi MM, Nguyen KL, Lake JE, Liao D, Khodabakhshian A, Guerrero M, Shufelt CL, Bairey Merz CN, Jordan WC, Daar ES, Bhattacharya D, Chew KW. PMID: 37788081; PMCID: PMC10841736.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    23. Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. bioRxiv. 2023 Sep 17. Phan T, Zitzmann C, Chew KW, Smith DM, Daar ES, Wohl DA, Eron JJ, Currier JS, Hughes MD, Choudhary MC, Deo R, Li JZ, Ribeiro RM, Ke R, Perelson AS, ACTIV-2/A5401 Study Team. PMID: 37745410; PMCID: PMC10515893.
      View in: PubMed   Mentions:
    24. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016. PLoS One. 2023; 18(9):e0290889. Kim J, Newcomb CW, Carbonari DM, Torgersen J, Althoff KN, Kitahata MM, Klein MB, Moore RD, Reddy KR, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Lim JK, Gill MJ, Chew K, Sterling TR, Hull M, Seaberg EC, Kirk GD, Coburn SB, Lang R, McGinnis KA, Gebo KA, Napravnik S, Kim HN, Lo Re V, North American AIDS Cohort Collaboration on Research and Design of IeDEA. PMID: 37656704; PMCID: PMC10473492.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    25. Variant-Specific Viral Kinetics in Acute COVID-19. J Infect Dis. 2023 08 31; 228(Suppl 2):S136-S143. Ribeiro RM, Choudhary MC, Deo R, Giganti MJ, Moser C, Ritz J, Greninger AL, Regan J, Flynn JP, Wohl DA, Currier JS, Eron JJ, Hughes MD, Smith DM, Chew KW, Daar ES, Perelson AS, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37650233; PMCID: PMC10469346.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    26. Immune Status and SARS-CoV-2 Viral Dynamics. J Infect Dis. 2023 08 31; 228(Suppl 2):S111-S116. Li Y, Moser C, Aga E, Currier JS, Wohl DA, Daar ES, Ritz J, Greninger AL, Sieg S, Parikh UM, Coombs RW, Hughes MD, Eron JJ, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 37650232; PMCID: PMC10469582.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    27. Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial. J Infect Dis. 2023 08 31; 228(Suppl 2):S83-S91. Chew KW, Moser C, Yeh E, Wohl DA, Daar ES, Ritz J, Javan AC, Eron JJ, Currier JS, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650237; PMCID: PMC10469584.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    28. ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients. J Infect Dis. 2023 08 31; 228(Suppl 2):S77-S82. Currier JS, Moser C, Eron JJ, Chew KW, Smith DM, Javan AC, Wohl DA, Daar ES, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650231; PMCID: PMC10469341.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    29. Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial. J Infect Dis. 2023 08 31; 228(Suppl 2):S92-S100. Moser CB, Chew KW, Ritz J, Newell M, Javan AC, Eron JJ, Daar ES, Wohl DA, Currier JS, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650234; PMCID: PMC10686688.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    30. Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19. J Infect Dis. 2023 08 31; 228(Suppl 2):S117-S125. Giganti MJ, Chew KW, Eron JJ, Li JZ, Pinilla M, Moser C, Javan AC, Fischer WA, Klekotka P, Margolis D, Wohl DA, Coombs RW, Daar ES, Smith DM, Currier JS, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650230; PMCID: PMC10469105.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    31. Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials. J Infect Dis. 2023 08 31; 228(Suppl 2):S101-S110. Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Bender Ignacio R, Daar ES, Wohl DA, Currier JS, Eron JJ, Smith DM, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 37650235; PMCID: PMC10469328.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    32. Long COVID After Bamlanivimab Treatment. J Infect Dis. 2023 08 31; 228(Suppl 2):S126-S135. Evering TH, Moser CB, Jilg N, Yeh E, Sanusi B, Wohl DA, Daar ES, Li JZ, Klekotka P, Javan AC, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, ACTIV-2/A5401 Study Team. PMID: 37650236; PMCID: PMC10686694.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    33. Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19. J Infect Dis. 2023 07 14; 228(2):133-142. Taiwo BO, Chew KW, Moser C, Wohl DA, Daar ES, Li JZ, Greninger AL, Bausch C, Luke T, Hoover K, Neytman G, Giganti MJ, Olefsky M, Javan AC, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM, ACTIV-2/A5401 Study Team. PMID: 36661240; PMCID: PMC10345463.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    34. Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19. Ann Intern Med. 2023 05; 176(5):658-666. Evering TH, Chew KW, Giganti MJ, Moser C, Pinilla M, Wohl DA, Currier JS, Eron JJ, Javan AC, Bender Ignacio R, Margolis D, Zhu Q, Ma J, Zhong L, Yan L, D'Andrea Nores U, Hoover K, Mocherla B, Choudhary MC, Deo R, Ritz J, Fischer WA, Fletcher CV, Li JZ, Hughes MD, Smith D, Daar ES, ACTIV-2/A5401 Study Team. PMID: 37068272; PMCID: PMC10150320.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    35. Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials. JAMA Netw Open. 2023 04 03; 6(4):e2310039. Bender Ignacio RA, Chew KW, Moser C, Currier JS, Eron JJ, Javan AC, Giganti MJ, Aga E, Gibbs M, Tchouakam Kouekam H, Johnsson E, Esser MT, Hoover K, Neytman G, Newell M, Daar ES, Fischer W, Fletcher CV, Li JZ, Greninger AL, Coombs RW, Hughes MD, Smith D, Wohl DA, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)–2/A5401 Study Team. PMID: 37099295; PMCID: PMC10134004.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    36. Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials. medRxiv. 2023 Mar 17. Moser CB, Chew KW, Giganti MJ, Li JZ, Aga E, Ritz J, Greninger AL, Javan AC, Daar ES, Currier JS, Eron JJ, Smith DM, Hughes MD. PMID: 36993419; PMCID: PMC10055451.
      View in: PubMed   Mentions:
    37. Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection. Ann Intern Med. 2023 03; 176(3):348-354. Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 36802755; PMCID: PMC10052317.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    38. Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019. Clin Infect Dis. 2023 02 18; 76(4):734-737. Li Y, Harrison LJ, Chew KW, Currier JS, Wohl DA, Daar ES, Evering TH, Wu R, Giganti M, Ritz J, Javan AC, Coombs RW, Moser C, Hughes MD, Eron JJ, Smith DM, Li JZ. PMID: 36210483; PMCID: PMC9619579.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    39. Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2023 02 08; 76(3):e571-e579. Chew KW, Wu K, Tassiopoulos K, Palella FJ, Naggie S, Utay NS, Overton ET, Sulkowski M. PMID: 36049028; PMCID: PMC10169398.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    40. Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD). J Patient Rep Outcomes. 2023 01 31; 7(1):8. Matza LS, Stewart KD, Naegeli AN, Mills KM, Coyne KS, Chew KW, Hughes MD, Smith DM. PMID: 36719546; PMCID: PMC9888338.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    41. Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nat Commun. 2023 Jan 19; 14(1):333. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, ACTIV-2/A5401 Study Team, Hughes MD, Smith DM. PMID: 36658128; PMCID: PMC9851732.
      View in: PubMed   Mentions: 1     Fields:    
    42. Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials. Clin Transl Sci. 2023 03; 16(3):524-535. Mitjà O, Reis G, Boulware DR, Spivak AM, Sarwar A, Johnston C, Webb B, Hill MD, Smith D, Kremsner P, Curran M, Carter D, Alexander J, Corbacho M, Lee TC, Hullsiek KH, McDonald EG, Hess R, Hughes M, Baeten JM, Schwartz I, Metz L, Richer L, Chew KW, Daar E, Wohl D, Dunne M. PMID: 36601684; PMCID: PMC10014689.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    43. Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2-specific memory T cell responses. JCI Insight. 2022 12 22; 7(24). Ramirez SI, Grifoni A, Weiskopf D, Parikh UM, Heaps A, Faraji F, Sieg SF, Ritz J, Moser C, Eron JJ, Currier JS, Klekotka P, Sette A, Wohl DA, Daar ES, Hughes MD, Chew KW, Smith DM, Crotty S, Accelerating COVID-19 Therapeutic Interventions and Vaccines–2/A5401 (ACTIV-2/A5401) Study Team. PMID: 36378539; PMCID: PMC9869965.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    44. Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co-infected patients in Ukraine. JGH Open. 2022 Dec; 6(12):894-903. Antoniak S, Chasela CS, Freiman MJ, Stopolianska Y, Barnard T, Gandhi MM, Liulchuk M, Tsenilova Z, Viktor T, Dible J, Wose Kinge C, Akpan F, Minior T, Sigwebela N, Mohamed S, Barralon M, Marange F, Cavenaugh C, Horst CV, Antonyak S, Xulu T, Chew KW, Sanne I, Rosen S, for EQUIP Health. PMID: 36514496; PMCID: PMC9730727.
      View in: PubMed   Mentions:
    45. Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19. Open Forum Infect Dis. 2022 Nov; 9(11):ofac618. Moser C, Li JZ, Eron JJ, Aga E, Daar ES, Wohl DA, Coombs RW, Javan AC, Bender Ignacio RA, Jagannathan P, Ritz J, Sieg SF, Parikh UM, Hughes MD, Currier JS, Smith DM, Chew KW, ACTIV-2/A5401 Study Team . PMID: 36467293; PMCID: PMC9709705.
      View in: PubMed   Mentions: 8  
    46. Left Atrial Mechanics and Diastolic Function Among People Living With Human Immunodeficiency Virus (from the Veterans Aging Cohort Study). Am J Cardiol. 2023 01 01; 186:50-57. Berg CJ, Patel B, Reynolds M, Tuzovic M, Chew KW, Sico JJ, Bhattacharya D, Butt AA, Lim JK, Bedimo RJ, Brown ST, Gottdiener JS, Warner AL, Freiberg MS, So-Armah KA, Nguyen KL. PMID: 36343446; PMCID: PMC10193525.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    47. Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial. Nat Microbiol. 2022 11; 7(11):1906-1917. Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes MD, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 36289399; PMCID: PMC9675946.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsCTClinical Trials
    48. Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19. JAMA Netw Open. 2022 10 03; 5(10):e2238867. Smith DM, Li JZ, Moser C, Yeh E, Currier JS, Chew KW, Hughes MD, ACTIV-2/A5401 Study Team. PMID: 36301549; PMCID: PMC9614575.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nat Commun. 2022 08 22; 13(1):4931. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs RW, Ritz J, Giganti M, Javan AC, Li Y, Choudhary MC, Deo R, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, ACTIV-2/A5401 Study Team, Hughes MD, Smith DM. PMID: 35995785; PMCID: PMC9395368.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    50. Viral and Symptom Rebound in Untreated COVID-19 Infection. medRxiv. 2022 Aug 02. Deo R, Choudhary MC, Moser C, Ritz J, Daar ES, Wohl DA, Greninger AL, Eron JJ, Currier JS, Hughes MD, Smith DM, Chew KW, Li JZ, ACTIV-2/A5401 Study Team. PMID: 35982660; PMCID: PMC9387151.
      View in: PubMed   Mentions: 1  
    51. Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS-CoV-2 Infection. Clin Pharmacol Ther. 2022 12; 112(6):1207-1213. Bender Ignacio RA, Wohl DA, Arends R, Pilla Reddy V, Mu Y, Javan AC, Hughes MD, Eron JJ, Currier JS, Smith D, Chew KW, Gibbs M, Fletcher CV. PMID: 35797235; PMCID: PMC9349574.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    52. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques. Front Immunol. 2022; 13:945706. Valentin A, Bergamaschi C, Rosati M, Angel M, Burns R, Agarwal M, Gergen J, Petsch B, Oostvogels L, Loeliger E, Chew KW, Deeks SG, Mullins JI, Pavlakis GN, Felber BK. PMID: 35935984; PMCID: PMC9355630.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    53. LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients. Biomark Med. 2022 08; 16(11):839-846. Altinbas A, Holmes JA, Salloum S, Lidofsky A, Alatrakchi N, Somsouk M, Hunt P, Deeks S, Chew KW, Lauer G, Kruger A, Lin W, Chung RT. PMID: 35786977; PMCID: PMC9437769.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection. Cell Rep Med. 2022 07 19; 3(7):100678. Boucau J, Chew KW, Choudhary MC, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, POSITIVES study team, Li JZ, Barczak AK, ACTIV-2/A5401 Study Team. PMID: 35793677; PMCID: PMC9213028.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    55. Cohort study of familial viral hepatitis and risks of paediatric cancers. Int J Epidemiol. 2022 05 09; 51(2):448-457. Heck JE, Wu CK, Huang X, Chew KW, Tong M, Federman N, Ritz B, Arah OA, Li CY, Yu F, Olsen J, Hansen J, Lee PC. PMID: 34966942; PMCID: PMC9308392.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    56. Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set. J Viral Hepat. 2022 06; 29(6):474-486. Morgan JR, Marsh E, Savinkina A, Shilton S, Shadaker S, Tsertsvadze T, Kamkamidze G, Alkhazashvili M, Morgan T, Belperio P, Backus L, Doss W, Esmat G, Hassany M, Elsharkawy A, Elakel W, Mehrez M, Foster GR, Wose Kinge C, Chew KW, Chasela CS, Sanne IM, Thanung YM, Loarec A, Aslam K, Balkan S, Easterbrook PJ, Linas BP. PMID: 35278339; PMCID: PMC9248016.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    57. Association of HIV Serostatus and Inflammation With Ascending Aortic Size. J Am Heart Assoc. 2022 03 15; 11(6):e023997. Minhas AS, Post WS, Liu B, Doria De Vasconcellos H, Haberlen SA, Feinstein M, Stosor V, Budoff M, Chew KW, Magnani JW, Brown T, Lima JAC, Wu KC. PMID: 35253450; PMCID: PMC9075303.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection. medRxiv. 2021 Dec 30. Boucau J, Chew KW, Choudhary M, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM, Li JZ, Barczak AK, ACTIV-2/A5401 Study Team. PMID: 35018382; PMCID: PMC8750705.
      View in: PubMed   Mentions: 3  
    59. Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial. medRxiv. 2021 Dec 21. Chew KW, Moser C, Daar ES, Wohl DA, Li JZ, Coombs R, Ritz J, Giganti M, Javan AC, Li Y, Malvestutto C, Klekotka P, Price K, Nirula A, Fischer W, Bala V, Ribeiro RM, Perelson AS, Fletcher CV, Eron JJ, Currier JS, Hughes MD, Smith DM, ACTIV-2/A5401 Study Team. PMID: 34981077; PMCID: PMC8722620.
      View in: PubMed   Mentions: 2  
    60. Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy. medRxiv. 2021 Sep 15. Choudhary MC, Chew KW, Deo R, Flynn JP, Regan J, Crain CR, Moser C, Hughes M, Ritz J, Ribeiro RM, Ke R, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Fletcher CV, Daar ES, Wohl DA, Eron JJ, Currier JS, Parikh UM, Sieg SF, Perelson AS, Coombs RW, Smith DM, Li JZ, ACTIV-2/A5401 Study Team. PMID: 34545376; PMCID: PMC8452115.
      View in: PubMed   Mentions: 2  
    61. Prospective cohort study of children exposed to hepatitis C virus through a pregnancy screening program. Int J Infect Dis. 2021 Sep; 110:62-68. Pinto RB, Ramos ARL, Padua LT, Swayze EJ, Cambou MC, Fiorini M, Melo M, Santos BR, Canti ICT, Silveira MLR, Solari MIG, de Correa JF, Chew K, Dos Santos Varella IR, Nielsen-Saines K. PMID: 34273517; PMCID: PMC8478836.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    62. Staying or moving: Results of a latent transition analysis examining intra-individual stability of recreational substance use among MSM in the Multicenter AIDS Cohort Study from 2004 to 2016. Drug Alcohol Depend. 2021 03 01; 220:108516. Noor SW, Hart TA, Okafor CN, Ware D, Chew KW, D'Souza G, Ho K, Friedman MR, Plankey M. PMID: 33485009; PMCID: PMC7901540.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    63. Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. Clin Gastroenterol Hepatol. 2022 02; 20(2):256-268. Lake JE, Overton T, Naggie S, Sulkowski M, Loomba R, Kleiner DE, Price JC, Chew KW, Chung RT, Corey KE. PMID: 33069882; PMCID: PMC9069630.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    64. Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in Myanmar. J Viral Hepat. 2021 01; 28(1):147-158. Min Thaung Y, Chasela CS, Chew KW, Minior T, Lwin AA, Sein YY, Drame N, Marange F, van der Horst C, Thwin HT, Freiman MJ, Gandhi MM, Bijl M, Wose Kinge C, Rosen S, Thura S, Mohamed S, Xulu T, Naing AY, Barralon M, Cavenaugh C, Kyi KP, Sanne I, for EQUIP Health. PMID: 32935438; PMCID: PMC7746582.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    65. Barriers to hepatitis C direct-acting antiviral therapy among HIV/hepatitis C virus-coinfected persons. J Gastroenterol Hepatol. 2021 Apr; 36(4):1095-1102. Jatt LP, Gandhi MM, Guo R, Sukhija-Cohen A, Bhattacharya D, Tseng CH, Chew KW. PMID: 32840904; PMCID: PMC7904967.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    66. Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. J Infect Dis. 2020 07 09; 222(Suppl 1):S63-S69. Neilan TG, Nguyen KL, Zaha VG, Chew KW, Morrison L, Ntusi NAB, Toribio M, Awadalla M, Drobni ZD, Nelson MD, Burdo TH, Van Schalkwyk M, Sax PE, Skiest DJ, Tashima K, Landovitz RJ, Daar E, Wurcel AG, Robbins GK, Bolan RK, Fitch KV, Currier JS, Bloomfield GS, Desvigne-Nickens P, Douglas PS, Hoffmann U, Grinspoon SK, Ribaudo H, Dawson R, Goetz MB, Jain MK, Warner A, Szczepaniak LS, Zanni MV. PMID: 32645158; PMCID: PMC7347082.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    67. Examination of Polypharmacy Trajectories Among HIV-Positive and HIV-Negative Men in an Ongoing Longitudinal Cohort from 2004 to 2016. AIDS Patient Care STDS. 2019 08; 33(8):354-365. Ware D, Palella FJ, Chew KW, Friedman MR, D'Souza G, Ho K, Plankey M. PMID: 31369298; PMCID: PMC6661916.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    68. Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance. BMC Infect Dis. 2019 Jul 15; 19(1):626. Kimble MM, Javanbakht M, Chew KW, Stafylis C, He D, Ramirez S, Baik Y, Saab S, Klausner JD. PMID: 31307403; PMCID: PMC6632203.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    69. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. J Infect Dis. 2018 09 22; 218(9):1394-1403. Lidofsky A, Holmes JA, Feeney ER, Kruger AJ, Salloum S, Zheng H, Seguin IS, Altinbas A, Masia R, Corey KE, Gustafson JL, Schaefer EA, Hunt PW, Deeks S, Somsouk M, Chew KW, Chung RT, Alatrakchi N. PMID: 29868909; PMCID: PMC6151081.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    70. Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016. PLoS One. 2018; 13(9):e0203890. Ware D, Palella FJ, Chew KW, Friedman MR, D'Souza G, Ho K, Plankey M. PMID: 30204807; PMCID: PMC6133387.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    71. Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES. Clin Infect Dis. 2017 Aug 15; 65(4):557-565. Butt AA, Yan P, Chew KW, Currier J, Corey K, Chung RT, Shuaib A, Abou-Samra AB, Butler J, Freiberg MS. PMID: 28444148; PMCID: PMC5850566.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    72. Hepatitis E Virus-Associated Meningoencephalitis in a Lung Transplant Recipient Diagnosed by Clinical Metagenomic Sequencing. Open Forum Infect Dis. 2017; 4(3):ofx121. Murkey JA, Chew KW, Carlson M, Shannon CL, Sirohi D, Sample HA, Wilson MR, Vespa P, Humphries RM, Miller S, Klausner JD, Chiu CY. PMID: 28721353; PMCID: PMC5508774.
      View in: PubMed   Mentions: 37  
    73. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons. J Int Med Res. 2017 Dec; 45(6):1693-1707. Chew KW, Liu CY, Ambale-Venkatesh B, Liao D, Horwich TB, Lima JAC, Bluemke DA, Paul Finn J, Butt AA, Currier JS. PMID: 28606026; PMCID: PMC5805202.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    74. Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers. Open Forum Infect Dis. 2017; 4(3):ofx109. Castrejón M, Chew KW, Javanbakht M, Humphries R, Saab S, Klausner JD. PMID: 28752101; PMCID: PMC5527269.
      View in: PubMed   Mentions: 25  
    75. Demographics and natural history of HIV-1-infected spontaneous controllers of viremia. AIDS. 2017 05 15; 31(8):1091-1098. Yang OO, Cumberland WG, Escobar R, Liao D, Chew KW. PMID: 28301422; PMCID: PMC5657480.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    76. Treatment optimization for HIV/HCV co-infected patients. Ther Adv Infect Dis. 2017 Jan; 4(1):18-36. Scott JA, Chew KW. PMID: 28357062; PMCID: PMC5360293.
      View in: PubMed   Mentions: 4  
    77. Virologic and immunologic aspects of HIV-hepatitis C virus coinfection. AIDS. 2016 10 23; 30(16):2395-2404. Chew KW, Bhattacharya D. PMID: 27427873; PMCID: PMC6039386.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    78. Low prevalence of hepatitis C co-infection in recently HIV-infected minority men who have sex with men in Los Angeles: a cross-sectional study. BMC Infect Dis. 2015 Nov 20; 15:538. Chew KW, Blum ML, Javanbakht M, Clare LE, Bornfleth LD, Bolan R, Bhattacharya D, Gorbach PM. PMID: 26590028; PMCID: PMC4654841.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    79. Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons. AIDS Res Hum Retroviruses. 2015 Jul; 31(7):718-22. Chew KW, Bhattacharya D, McGinnis KA, Horwich TB, Tseng CH, Currier JS, Butt AA, ERCHIVES (Electronically Retrieved Cohort of HCV Infected Veterans) Study. PMID: 25858663; PMCID: PMC4505770.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    80. The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection. Open Forum Infect Dis. 2014 Dec; 1(3):ofu104. Chew KW, Hua L, Bhattacharya D, Butt AA, Bornfleth L, Chung RT, Andersen JW, Currier JS. PMID: 25734172; PMCID: PMC4324212.
      View in: PubMed   Mentions: 18  
    81. A new system to measure and compare hepatitis C virus replication capacity using full-length, replication competent viruses. J Virol Methods. 2013 Dec; 194(1-2):82-8. Lassmann B, Arumugaswami V, Chew KW, Lewis MJ. PMID: 23973740.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    82. Predictors of pneumonia severity in HIV-infected adults admitted to an Urban public hospital. AIDS Patient Care STDS. 2011 May; 25(5):273-7. Chew KW, Yen IH, Li JZ, Winston LG. PMID: 21488749; PMCID: PMC4056456.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    83. Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C. J Clin Gastroenterol. 2009 Aug; 43(7):686-91. Chew KW, Allen SA, Taylor LE, Rich JD, Feller E. PMID: 19295448; PMCID: PMC2936234.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    Kara's Networks
    Concepts (184)
    Derived automatically from this person's publications.
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _